These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26489633)

  • 1. Modified titration intratympanic gentamicin injection for unilateral intractable Ménière's disease.
    Liu B; Leng YM; Shi H; Zhou RH; Liu JJ; Zhang WJ; Zhang SL; Kong WJ
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):747-751. PubMed ID: 26489633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin injection for refractory ménière's disease (MD) has potential effect in preventing contralateral MD occurrence.
    Wu Y; Zhou Y; Yu J; Song Z; Dai C; Wang J
    Acta Otolaryngol; 2021 Jul; 141(7):657-662. PubMed ID: 33950779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC; Han JJ; Park J; Choi BY; Koo JW
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CASP9 genotype confers gentamicin susceptibility in intratympanic treatment of intractable vertigo caused by Ménière's disease.
    Huang CJ; Wan TK; Fang TY; Wang PC
    Acta Otolaryngol; 2019 Apr; 139(4):336-339. PubMed ID: 30907242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instrumental head impulse test changes after intratympanic gentamicin for unilateral definite Ménière's disease: A systematic review and meta-analysis.
    Marques PS; Dias CC; Perez-Fernandez N; Spratley J
    Auris Nasus Larynx; 2018 Oct; 45(5):943-951. PubMed ID: 29402608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of intratympanic gentamicin and dexamethasone in the treatment of intractable Meniere's disease].
    Wang QL; Guo XD; Mei XS; Li Y; Yao WJ; Yang XG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):96-99. PubMed ID: 29871195
    [No Abstract]   [Full Text] [Related]  

  • 10. Change of VOR gain and pure-tone threshold after single low-dose intratympanic gentamicin injection in Meniere's disease.
    Lee JY; Kim MB
    Acta Otolaryngol; 2020 Apr; 140(4):314-318. PubMed ID: 31909683
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
    Liu YF; Renk E; Rauch SD; Xu HX
    Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratympanic gentamicin titration therapy for intractable Meniere's disease.
    Atlas JT; Parnes LS
    Am J Otol; 1999 May; 20(3):357-63. PubMed ID: 10337978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin in monolateral Meniere's disease: our experience.
    Bertino G; Durso D; Manfrin M; Casati L; Mira E
    Eur Arch Otorhinolaryngol; 2006 Mar; 263(3):271-5. PubMed ID: 16021460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K; Ata N
    Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intratympanic gentamicin in Menière's disease].
    Huang W; Xu H; Gao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease.
    Abou-Halawa AS; Poe DS
    Otol Neurotol; 2002 Jul; 23(4):494-502; discussion 502-3. PubMed ID: 12170152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.